Sangamo Biosciences reported $593.91M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amgen AMGN:US USD 63.7B 4.41B
Avrobio Inc AVRO:US USD 129.5M 16.75M
Bayer BAYN:GR EUR 131.01B 2.22B
Biocryst Pharmaceuticals BCRX:US USD 558.59M 48.06M
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Gilead Sciences GILD:US USD 62.56B 313M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
Karyopharm Therapeutics KPTI:US USD 231.24M 25.24M
Merk MRK:US USD 107.08B 14M
Novartis NOVN:VX USD 118.46B 4.45B
Omeros OMER:US USD 457.55M 111.91M
Pfizer PFE:US USD 195.35B 60M
Regulus Therapeutics RGLS:US USD 52.13M 2.17M
Roche Holding ROG:VX 86.74B 5.58B
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Ultragenyx Pharmaceutical RARE:US USD 1.62B 297.85M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
Ziopharm Oncology ZIOP:US USD 67.34M 6.59M